Resting state functional magnetic resonance Image-guided rTMS for the treatment of autism spectrum disorders

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400092741

Enrollment

Unknown

Registered

2024-11-22

Start date

2024-12-01

Completion date

Unknown

Last updated

2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder

Interventions

TMS group with the traditional 5-cm rule :TMS with the traditional 5-cm rule

Individualized group:TMS therapy based on subtype-based calculations for individualized targets

Normal control group:None

Eligibility

Sex/Gender

All

Age

3 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1.Age 3-18 years; 2.Meet the DSM-5 diagnostic criteria for Autism spectrum disorder 3.The score of Childhood Autism Rating Scale should not be less than 30.

Exclusion criteria

Exclusion criteria: Trisomy 21 syndrome; Schizophrenia; Speech and language development disorders; Hearing impairment; History of febrile convulsions and seizures; History of craniocerebral trauma, craniocerebral infection, brain tumor, etc. History of craniocerebral metal implantation or intracranial surgery; History of taking antipsychotic or antiepileptic drugs.

Design outcomes

Primary

Measure	Time frame
Childhood Autism Rating Scale;Social Responsiveness Scale;Repetitive Behavior Scale-Revised;Autism-Spectrum Quotient;Eye tracking;Magnetic resonance imaging;	—

Countries

China

Contacts

Public ContactZhang Bin; Li Peiying

Tianjin Anding Hospital

zhang.bin845@foxmail.com+86 189 8893 2815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026